Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T12:50:50.700Z.
Calculation as of: 2026-10-06T12:50:50.700Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b47dc168d162d1a8799ce58e4fab29ef684c29fe4f2d0edb18e5266ad2cbc09
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-05-20.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| biote Corp. (BTMD) | $49.40M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $49.50M | N/A | 3.45 | 2.03 | 2.35 |
| Clene Inc. (CLNN)vs › | $49.96M | N/A | 4.45 | 27.22 | 162.33 |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | 15.21 | 11.51 | 9.36 | 5.08 |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | 2.23 | 1.92 | 1.92 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.75 | 0.72 | 1.87 | 2.54 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 14.02 | 23.34 | 19.23 | 19.23 |
| INmune Bio, Inc. (INMB)vs › | $51.58M | 2.53 | 1.94 | 3.26 | 2.92 |
| BioStem Technologies, Inc. (BSEM)vs › | $46.79M | 1.69 | 2.19 | 8.02 | 8.02 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | 1.14 | 2.46 | 2.46 | 2.46 |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2022-05-20 | 18.36 |
| 2022-05-19 | 17.96 |
| 2022-05-18 | 18.33 |
| 2022-05-17 | 18.31 |
| 2022-05-16 | 18.29 |
| 2022-05-13 | 18.29 |
| 2022-05-12 | 18.30 |
| 2022-05-11 | 18.31 |
| 2022-05-10 | 18.27 |
| 2022-05-09 | 18.29 |
| 2022-05-06 | 18.27 |
| 2022-05-05 | 18.29 |
| 2022-05-04 | 18.20 |
| 2022-05-03 | 18.20 |
| 2022-05-02 | 18.20 |
| 2022-04-29 | 18.21 |
| 2022-04-28 | 18.20 |
| 2022-04-27 | 18.21 |
| 2022-04-26 | 18.21 |
| 2022-04-25 | 18.20 |
| 2022-04-22 | 18.20 |
| 2022-04-21 | 18.20 |
| 2022-04-20 | 18.20 |
| 2022-04-19 | 18.20 |
| 2022-04-18 | 18.16 |
| 2022-04-14 | 18.18 |
| 2022-04-13 | 18.16 |
| 2022-04-12 | 18.16 |
| 2022-04-11 | 18.16 |
| 2022-04-08 | 18.16 |
| 2022-04-07 | 18.16 |
